The NHS will roll out a new immunotherapy that could offer women with advanced endometrial cancer significant extra time before their disease progresses, compared with standard chemotherapy alone. Trials have shown that adding dostarlimab (Jemperli) to chemotherapy can slow the spread of certain forms of endometrial cancer, giving patients the hope of more time to […]
Read More on the NHS website.